1. Alpha-synuclein: structure and function Alpha-synuclein (α-Syn) is a highly conserved small acidic protein with a molecular mass of 14 kDa, predominantly found in presynaptic terminals of neurons. It consists of three basic domains: an amphiphilic N-terminal region (NT; amino acid residues (AAA) 1-60), a central hydrophobic non-amyloid component domain (NAC; AAA 61-95), and an acidic C-terminal domain (CT; AAA 95-140), which contributes to The NT is an amphiphilic region consisting of amino acid (AAA) residues (AAA 1-60). The downstream region NAC (AAA 61-95) is hydrophobic and possibly involved in protein aggregation. The CT (AAA 95-140) contains several acidic AAAs, which are required for calcium binding and chaperone-like activity and play the role of a chaperone (regulation of synaptic vesicle binding, suggesting the physiological role for α-Syn in the membrane) [1]. In its natural state, α-Syn is natively unfolded and intrinsically disordered protein, but could potentially adopt helical conformations upon membrane binding is a monomeric protein characterized by low hydrophobicity and high charge. Similar to prion protein, α-Syn is an unfolded and intrinsically disordered protein. It is likely that physiologically, it exists as an equilibrium mixture of the unfolded monomeric form and helical forms, or oligomers [2,3].; thanks to its proposed ability to adopt an alpha-helix form when bound to cell membranes [3]. Although the biological function of α-Syn is not fully understood, evidence suggests that it plays an important role in modulating synaptic vesicle transport and neurotransmitter release during synapse formation While its exact biological role remains not fully understood, α-Syn is believed to regulate synaptic vesicle trafficking and neurotransmitter release [4].1.1. Alpha-synuclein: aggregation, seeding and prion-like spreading Under pathological conditions, α-Syn can self-aggregate, potentially propagate in a prion-like manner, and accumulate into tetramers to form tetrameric conformers (with an approximate size of ~58 kDa). The imbalance between the monomeric and tetrameric states makes it prone particularly susceptible to conformational changes, forming including the assembly of betafolded sheet-rich structures, which are typical of amyloid fibrils [1,5,6]. The conformationally Altered α-Syn molecule with beta-sheet aggregates structure tends to aggregate, engulfing normally structured α-Syn molecules and converting them into abnormally aggregated nonfibrillar and fibrillar forms. The as-of-yet poorly understood seeding process leads to the fibrillization of oligomers, with In addition, most seeding-efficient α-Syn forms often being small fibrillar aggregates (~ 50 nm) 50 nm long [7]. Oligomers are toxic, causing and induce cellular dysfunction, including synaptic, mitochondrial, lysosomal, and autophagic impairments, and can form pores in cell membranes incressinsg its permeability dysfunction.They have also been reported to create pores in cell membranes, thereby increasing membrane permeability and causing neurotoxicity [1]. α-Syn is proposed to spread in the nervous system in a prion-like manner, although the The detailed molecular pathways of underlying seeding, exocytosis, and the potential interaction of α-Syn with extracellular components are unclear. Misfolded α-Syn seeds are secreted into from donor cells to the interstitial compartment, either as free protein or in vesicles, and spread rapidly through neurons, aggregating in affected cells as naked protein or in vesicles.Experimental models show that the α-Syn seeds spread (at a rate of less than 24 hours) through neuronal cells and aggregate in affected neurons [1]. Furthermore, aggregates of α-Syn are detected in extracellular spaces, they circulate in biological fluids (CSF, blood) and could be detected in biological samples other than the central nervous system (skin, salivary and lacrimal glands, intestinal mucosa). The process of protein misfolding, aggregation, and spreading appears to begin decades before the onset of clinical symptoms [8,9]. Interestingly, α-Syn does not always aggregate and spread in the same manner. It is currently almost certain that the aggregated form α-Syn may have different conformational structures, usually referred to as conformational strains, which probably affect various brain regions and lead to different clinical phenotypes [5].Misfolded α-Syn can act as a seed that induces the conversion of normal cellular α-Syn, allowing the transcellular spread of Lewy bodies (LB) pathology in a prion-like manner [10].The aggregation of α-Syn follows a seeding/nucleation mechanism that is characterized by the progressive formation of oligomers, protofibrils, and fibrils that culminate in LB or glial cytoplasmic inclusions (GCIs). In the seeding/nucleation polymerization reaction, the first and rate-limiting step is the formation of a nucleus, which then forms large aggregates at the expense of the monomeric protein. The nucleus can serve as a seed to catalyze further polymerization, most likely remaining misfolded to the protein oligomer, which can be highly neurotoxic even before it grows into larger aggregates. A typical feature of the seeding/nucleation process is that adding preformed seeds can significantly accelerate the aggregation process by scooping soluble native protein into the growing aggregate. The seeding/nucleation mechanism provides a biochemical explanation for the propagation of misfolded proteins between cells and tissues.The molecular mechanisms of aggregate formation in the prion protein and α-Syn are similar.This suggests that misfolded proteins can spread between cells and tissues to initiate and propagate pathogenesis. A substantial body of evidence from the last decade demonstrates that misfolded α-Syn aggregates can move from cell to cell,...